While conformity was found among the centers regarding genetic tests to diagnose TS, GH use and hormone replacement therapy in TS, there were apparent discrepancies between centers and the current consensus regarding healthcare-related surveillance issues. This evidence concerns the gene GH1 and Timothy syndrome.